Home › Trial NCT02420977
Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer
- Trial IDNCT02420977
- StatusCompleted
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Enrollment23
- Start date2018-12-06
- ConditionsAdvanced Prostate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.